Target Price | $4.67 |
Price | $0.13 |
Potential |
3,395.63%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Citius Pharmaceuticals Inc 2025 .
The average Citius Pharmaceuticals Inc target price is $4.67.
This is
3,395.63%
register free of charge
$6.00
4,394.38%
register free of charge
$4.00
2,896.25%
register free of charge
|
|
A rating was issued by 3 analysts: 2 Analysts recommend Citius Pharmaceuticals Inc to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Citius Pharmaceuticals Inc stock has an average upside potential 2025 of
3,395.63%
register free of charge
|
Sep '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.22 | -0.22 |
4.35% | 0.00% | |
P/E | negative |
2 Analysts have issued a Citius Pharmaceuticals Inc forecast for earnings per share. The average Citius Pharmaceuticals Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Citius Pharmaceuticals Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.